Insider · CIK 0001369900

Berkowitz Noah

Reports to the SEC for 3 companies · PHILADELPHIA, PA

sec.gov

Transactions

Companies

Filings

CIK

0001369900

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Stock Options (Right to Buy)A Award	Chief Medical Officer	AAward	+135K sh	—	—	135,000
2026-09-30	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Performance Stock UnitsA Award	Chief Medical Officer	AAward	+135K sh	—	—	135,000
2026-09-30	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Restricted Stock UnitsA Award	Chief Medical Officer	AAward	+180K sh	—	—	180,000
2026-05-11	ARVNARVINAS, INC.S Sale	Chief Medical Officer	SSale	−11.1K sh	$9.94	−$110K	191,395
2026-03-18	ARVNARVINAS, INC.S Sale	Chief Medical Officer	SSale	−6,435 sh	$11.10	−$71.4K	202,503
2026-02-26	ARVNARVINAS, INC.A Award	Chief Medical Officer	AAward	+45K sh	—	—	208,938
2026-02-26	ARVNARVINAS, INC. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+67K sh	—	—	67,000
2026-02-13	ARVNARVINAS, INC.S Sale	Chief Medical Officer	SSale	−5,685 sh	$11.89	−$67.6K	163,938
2025-05-09	ARVNARVINAS, INC. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+91K sh	—	—	91,000
2025-05-09	ARVNARVINAS, INC.A Award	Chief Medical Officer	AAward	+59.6K sh	—	—	169,623
2025-03-18	ARVNARVINAS, INC.S Sale	Chief Medical Officer	SSale	−8,658 sh	$8.59	−$74.4K	110,023
2025-02-13	ARVNARVINAS, INC.A Award	Chief Medical Officer	AAward	+55.2K sh	—	—	118,681
2025-02-13	ARVNARVINAS, INC. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+84.3K sh	—	—	84,330
2024-03-18	ARVNARVINAS, INC.A Award	Chief Medical Officer	AAward	+63.5K sh	—	—	63,452
2024-03-18	ARVNARVINAS, INC. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+93.9K sh	—	—	93,879
2008-07-22	Synvista Therapeutics, Inc.Employee Stock Options - (Right to Buy)A Award	Director, President & CEO, 10% Owner	AAward	+50K sh	—	—	50,000
2008-07-22	Synvista Therapeutics, Inc.Employee Stock Options - (Right to Buy)A Award	Director, President & CEO, 10% Owner	AAward	+50K sh	—	—	50,000
2007-10-02	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−100 sh	$2.90	−$290	150,634
2007-10-02	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−800 sh	$2.80	−$2,240	151,734
2007-10-02	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−1,000 sh	$2.77	−$2,770	150,734
2007-10-01	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−300 sh	$3.06	−$918	152,534
2007-10-01	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−1,100 sh	$3.00	−$3,300	152,834
2007-10-01	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−700 sh	$3.16	−$2,212	153,934
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−1,258 sh	$3.05	−$3,836.9	154,912
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−278 sh	$3.06	−$850.68	154,634
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−68 sh	$3.10	−$210.8	156,308
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−138 sh	$3.08	−$425.04	156,170
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−278 sh	$3.18	−$884.04	157,279
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−138 sh	$3.15	−$434.7	157,141
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−139 sh	$3.28	−$455.92	157,695
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−78 sh	$3.13	−$244.14	157,063
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−619 sh	$3.11	−$1,925.09	156,444
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−122 sh	$3.06	−$373.32	114,756
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−267 sh	$3.11	−$830.37	115,546
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−32 sh	$3.10	−$99.2	115,482
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−62 sh	$3.15	−$195.3	115,849
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−36 sh	$3.13	−$112.68	115,813
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−32 sh	$3.11	−$99.52	115,514
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−62 sh	$3.08	−$190.96	115,420
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−61 sh	$3.28	−$200.08	116,095
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−62 sh	$3.22	−$199.64	116,033
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−68 sh	$3.11	−$211.48	156,376
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−122 sh	$3.18	−$387.96	115,911
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−542 sh	$3.05	−$1,653.1	114,878
2007-09-17	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−138 sh	$3.22	−$444.36	157,557
2007-09-14	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−65 sh	$3.50	−$227.5	117,412
2007-09-14	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−33 sh	$3.40	−$112.2	117,477
2007-09-14	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−65 sh	$3.50	−$227.5	117,347
2007-09-14	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−33 sh	$3.75	−$123.75	117,831
2007-09-14	Synvista Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO, 10% Owner	DDisposition to Issuer	−321 sh	$3.38	−$1,084.98	117,510

Recent filings

Accepted (ET)
Oct 24
Berkowitz Noah0001104659-26-113342
SEC(opens sec.gov)
May 134
Berkowitz Noah0001628280-26-034606
SEC(opens sec.gov)
Mar 194
Berkowitz Noah0001628280-26-019950
SEC(opens sec.gov)
Mar 24
Berkowitz Noah0001628280-26-013533
SEC(opens sec.gov)
Feb 184
Berkowitz Noah0001628280-26-009300
SEC(opens sec.gov)
May 134
Berkowitz Noah0001655759-25-000087
SEC(opens sec.gov)
Mar 194
Berkowitz Noah0001655759-25-000064
SEC(opens sec.gov)
Feb 184
Berkowitz Noah0001655759-25-000023
SEC(opens sec.gov)
Mar 214
Berkowitz Noah0001655759-24-000040
SEC(opens sec.gov)
Jul 244
Berkowitz Noah0001209191-08-043565
SEC(opens sec.gov)
Oct 34
Berkowitz Noah0001209191-07-056764
SEC(opens sec.gov)

Companies

Address

C/O IOVANCE BIOTHERAPEUTICS, INC. 300 ROUSE BLVD.

PHILADELPHIA, PA, 19112